Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Abbott Laboratories - SIC # 200 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABT
New York
200
www.abbott.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Abbott Laboratories
Is It Time To Revisit Abbott Laboratories (ABT) After This Year’s Share Price Slump?
- Jun 8th, 2026 12:09 pm
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
- Jun 8th, 2026 10:16 am
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
- Jun 8th, 2026 7:00 am
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
- Jun 8th, 2026 12:05 am
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option
- Jun 7th, 2026 9:44 pm
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
- Jun 6th, 2026 7:00 am
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?
- Jun 5th, 2026 2:15 am
Cardiac Monitoring & Rhythm Management Devices Market by Type, Application, End User - Global Forecast to 2031
- Jun 5th, 2026 2:02 am
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
- Jun 4th, 2026 7:57 am
Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott”
- Jun 4th, 2026 4:58 am
Assessing Abbott Laboratories (ABT) Valuation After New Diabetes Sensor And Cancer Screening Tailwinds
- Jun 3rd, 2026 6:17 pm
Medtronic Stock Is Defying a Market Selloff After Earnings. Here’s Why.
- Jun 3rd, 2026 2:45 pm
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
- Jun 3rd, 2026 11:44 am
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
- Jun 3rd, 2026 5:53 am
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
- Jun 3rd, 2026 5:00 am
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
- Jun 3rd, 2026 4:47 am
How A Steady Valuation Is Shaping The Evolving Abbott Laboratories (ABT) Investment Story
- Jun 2nd, 2026 7:08 pm
Why Investors Are Cautious on Abbott Laboratories (ABT)?
- Jun 2nd, 2026 10:33 am
Can ISRG's Digital Roadmap Unlock the Next Phase of Robotic Surgery?
- Jun 2nd, 2026 8:59 am
Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031
- Jun 2nd, 2026 2:49 am
Scroll